Skip to NavigationSkip to content

News

0
Bristol-Myers Squibb has agreed to sell off Celgene’s psoriasis treatment Otezla, to appease antitrust regulators.
0
Pfizer’s Talzenna (talazoparib) has secured approval in Europe from the European Commission, the drugmaker has confirmed, as a monotherapy for the...
0
Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil.
0
Vertex has announced that the FDA has chosen to expand the existing authorisation on its cystic fibrosis (CF) therapy Symdeko.

Features

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit appears as an...